Interestingly, we find that deep somatic deletions do frequently contribute to biallelic loss of BRCA2 or RAD51C, occurring in 10% of CHORD-HRD patients pan-cancer (Supplementary Data 5). The gene discussed is RAD51C; the disease is cancer.